News
New CBMS supplemental grant aims to enhance laboratory safety practices
Jul. 18, 2024—Given the occurrence of tragic accidents and near-misses at research institutions across the country, cultivating a culture of laboratory safety in academic institutions has been a pressing concern for governmental funding agencies. Thanks to a training grant supplement from the National Institute of General Medical Sciences awarded last year, Vanderbilt campus partners collaborated to execute...
New drug candidates targeting blood clots developed through computer-aided drug design
Jul. 18, 2024—A team of Vanderbilt researchers has created a new series of drug candidates against a hard-to-target receptor involved in the formation of blood clots. The research, spearheaded by the labs of Jens Meiler, research professor of chemistry, Craig Lindsley, Executive Director of Warren Center for Neuroscience Drug Discovery and professor of pharmacology, and Heidi Hamm,...
Jeffrey Spraggins named director of Vanderbilt University Mass Spectrometry Research Center
Jul. 17, 2024—Jeffrey Spraggins, associate professor of cell and developmental biology, biochemistry, and chemistry, has been named director of the Mass Spectrometry Research Center. He succeeds Richard Caprioli, Stanford Moore Chair in Biochemistry, who established the MSRC in 1998 and who is retiring this summer.
Osheroff Named the 2024 Recipient of the Lillian B. Nanney Award for Outstanding Service to the VUSM/VUMC Community of Educators
Jul. 12, 2024—The Lillian B. Nanney Award for Outstanding Service to the VUSM/VUMC Community of Educators is a lifetime achievement award established to recognize an Academy for Excellence in Education faculty member who has demonstrated sustained outstanding service to the Vanderbilt community of educators. This year’s winner is Neil Osheroff, PhD, John G. Coniglio Professor of Biochemistry and professor...
Spraggins Named 2024 Chancellor Faculty Fellow
Jul. 12, 2024—Thirteen outstanding faculty members from across the university have been selected for the 2024 cohort of Chancellor Faculty Fellows. This group is composed of highly accomplished, recently tenured faculty from a wide variety of disciplines and areas of expertise.
New structures offer insight into how a bacterial motor powers bacterial chemotaxis, a key infectious process
Jul. 12, 2024—Bacteria existed for millennia before humans and have been infecting us from the beginning. Although we can treat infections through pharmaceuticals, bacteria continue to become resistant to treatment thanks to their rapid evolution. Bacterial infections remain a leading cause of morbidity and mortality in 2024, resulting in nearly eight million annual deaths globally. One key...
Hodges lab sheds new light on mechanisms of gene regulatory divergence between species
Jul. 12, 2024—Closely related animal species can look physically different, but you might be surprised to learn that those differences can result not only from DNA sequence changes that alter proteins’ structure or function, but also because changes in the DNA affect how those proteins are expressed. To add to that, not all differences between species can...
David Cortez wins Protein Society award for contributions to basic protein science
Jul. 12, 2024—David Cortez, the Richard N. Armstrong Ph.D. Professor of Innovation in Biochemistry and chair of biochemistry, won The Hans Neurath Award, a 2024 Protein Society Award, for recent contributions of exceptional merit to basic protein research.
Pietenpol to receive ASCO’s highest honor
Jul. 12, 2024—Jennifer Pietenpol, PhD, Executive Vice President for Research, and chief scientific and strategy officer for Vanderbilt University Medical Center, will be recognized at the annual meeting of the American Society of Clinical Oncology (ASCO) with one of its highest honors.
Kimryn Rathmell named American Society of Clinical Oncology (ASCO)
Jun. 23, 2023—Kimryn Rathmell, MD, PhD, was recently inducted as a American Society of Clinical Oncology (ASCO) fellow for her record of volunteer service, dedication and commitment to the organization.
Ascano and Jackson named 2023 Chancellor Faculty Fellows
Jun. 7, 2023—Thirteen outstanding faculty members from across the university have been selected for the 2023 cohort of Chancellor Faculty Fellows. This group is composed of highly accomplished, recently tenured faculty from a wide variety of disciplines and areas of expertise. “As we reflect on the 150th anniversary of our founding, we’re asking our university community to...
Osheroff honored with APMEC mentoring award
Jun. 2, 2023—Dr. Neil Osheroff was the keynote speaker at the 20th annual Asia Pacific Medical Education Conference (APMEC) in Singapore and received their MILES (Mentoring, Innovation, and Leadership in Educational Scholarship) Award. APMEC, an Asian medical education conference, had over 1,000 delegates in attendance. I am sharing a picture of the award ceremony. Pictured here is...
Lourdes Estrada promotion
Jun. 2, 2023—Please join me in congratulating Dr. Lourdes Estrada for her promotion to Professor of Biochemistry, educator track! Dr. Estrada has made outstanding contributions to the Vanderbilt School of Medicine through her teaching, mentoring, and service. She is an amazing educational leader at Vanderbilt with major innovative contributions to our MSTP, medical, and graduate education programs....
Vanderbilt and Bruker establish first of its kind Mass Spectrometry Center of Excellence
May. 2, 2023—Vanderbilt University and Bruker Daltonics, a manufacturer of scientific instruments for molecular and materials research, are collaborating to establish a Mass Spectrometry Center of Excellence housed in the Mass Spectrometry Research Center at Vanderbilt University School of Medicine Basic Sciences. The MSRC is a university-wide facility serving the university and Vanderbilt University Medical Center. It...
Cortez lab work featured in Research News article
May. 2, 2023—An international collaboration steered by David Cortez, Richard N. Armstrong, Ph.D. Chair for Innovation in Biochemistry, explored how cells tolerate DNA damage and genome instability—and they arrived at conclusions that will redirect research into DNA replication as a target for cancer and disease therapeutics.